Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
1991.8500
23.40
(
1.19
%)
NSE
Mar 17, 2025
15:31 PM
33.39% Gain from 52W Low
Volume:
550.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
13 Mar 2025
US FDA Approval
1991.85
1.19%
LUPIN LIMITED
Hold:
Lupin Ltd.
by
Geojit BNP Paribas
Target: 2132 | Upside : 7.0%
Target
Geojit BNP Paribas
Lupin Ltd. has an
average target
of 2329.44 from 9 brokers.
More from Lupin Ltd.
Recommended
Market closes higher, Blackstone to buy up to 66% of Kolte-Patil for around Rs 1,800 crore
Trendlyne Marketwatch |
17 Mar 2025, 03:58PM
Musk, Adani, and the double-edged sword of politics | Screener: Stocks with high buy calls from analysts
The Baseline |
15 Mar 2025
Lupin expects normalization by September quarter
|
17 Apr 2020, 02:22PM